<html>
<head>
<title>D075.P.100.B.31.WSJ910418-0105</title>
</head>
<body bgcolor="white">
<a name="1">[1]</a> <a href="#1" id=1>Apparently by coincidence, Abbott Laboratories announced on Tuesday that is developing a high blood pressure drug that works by inhibiting the activity of renin.</a>
<a name="2">[2]</a> <a href="#2" id=2>The Cornell cardiologist has argued that in many people with high blood pressure the activity of the renin in the blood is much higher than is warranted by the amount of salt in the blood.</a>
<a name="3">[3]</a> <a href="#3" id=3>The incidence in the high renin patients was more than double the incidence in those with a normal renin profile -- 5.3 heart attacks per 1,000 person-years -- and more than triple that of the patients with a low renin profile, 3.3 per 1,000 person-years, Drs.</a>
</body>
</html>
